| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERON PHARMA | 530,919 | 16,798,000 | 90.87% | ||
| 2 | BG Medicine, Inc. | 3,066,461 | 1,687,000 | 9.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-007764, filed 2015.07.28).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.